Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0278883 (
metastatic melanoma
)
6,224
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TR3
was originally recognized for its role in the regulation of cell survival and differentiation, however, it was recently found to be a potent pro-apoptotic protein. In order to characterize the role of
TR3
in melanoma cell apoptosis, we studied expression of
TR3
in melanoma cell lines and tissues, its subcellular distribution and function during apoptosis using various expression and RNA interference vectors. We found that
TR3
was constitutively expressed in both cultured melanoma cells and melanoma tissues.
TR3
expression was significantly decreased in advanced melanomas comparing to benign nevi. Over-expression of wild type
TR3
or mutant
TR3
lacking the DNA binding domain resulted in massive apoptosis in melanoma cells, whereas stable knockdown of
TR3
using RNA interference resulted in melanoma cell resistance to apoptosis induced by chemotherapeutic agents ATRA and cisplatin. We further demonstrated that apoptosis in melanoma cells was mediated, at least partially, through
TR3
mitochondrial translocation but not alteration in
TR3
expression levels. Our results suggest that
TR3
is an important apoptosis inducing factor in melanoma cells. Decreased expression of
TR3
in
metastatic melanoma
cells may contribute to their reduced apoptotic potential and increased resistance to chemotherapy.
...
PMID:Nuclear orphan receptor TR3/Nur77 mediates melanoma cell apoptosis. 1729 6